Group members

  • MARIA LUISA FERNANDEZ SANCHEZ

    Category:
    TITULAR DE UNIVERSIDAD
    Departament:
    QUIMICA FISICA Y ANALITICA
    Area:
    QUIMICA ANALITICA
    E-mail:
    Phone:
    985103071

    Brief CV:

    María Luisa Fernández Sánchez holds a permanent position as Associate Professor in the Analytical Chemistry Area of the Department of Physical and Analytical Chemistry at the University of Oviedo since July of 2000. In 1983 she got her Master Thesis at the University de Oviedo and in 1989 her Ph.D. Degree in Chemistry at the University of Oviedo supervised by A. Sanz Medel. She has been visiting scientist at the research group of Prof. Barry Sharp in the Department of Chemistry at the University of Loughborough (England), Dr Joaquín Abian´s Group in the  Proteomics Laboratory, Instituto de Investigaciones Biomédicas de Barcelona -CSIC / UAB, Prof  Ricardo E Santelli´s Group  in Federal University of Rio de Janeiro and in the National Institute of Metrology, Quality and Technology (Brazil). She received the 2011 International Hippocrates of Medical Research on Human Nutrition Award of the Real Academia de Medicina del Principado de Asturias. She has published over 80 peer-reviewed journal articles, book chapters and co-authored of a patent, supervised 9 Ph.D. Thesis and over 30 Master and Degree Thesis.

    Her research interests focus around:  the

    • Application and development of methods of sample treatment, preconcentration and coupled techniques (LC-ICP-MS) for the speciation of essential and toxic elements in environmental samples, biological fluids and foods.
    • The use of stables isotopes in combination with ICP-MS and isotope pattern deconvolution (IPD) to study the bioavailability and metabolism of iron and selenium from nutritional supplements.
    • Metaloproteomics, integrating molecular mass spectrometry (MALDI-TOF and ESI) and atomic mass spectrometry (ICP-MS,) in combination with chromatographic separations and immunoassay approaches to identification of biomarkers for the early detection of cancer and degenerative diseases.
    • Development of tissue bioimaging techniques using LA-ICP-MS and MALDI-IMAGING-MS for the elucidation of the role of metalloproteins in breast cancer.